# Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE

> **NCT01450072** · NA · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 20 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DEVICE:** Selective Venography followed by therapeutic balloon angioplasty
- **OTHER:** Control arm

## Key facts

- **NCT ID:** NCT01450072
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-12
- **Final completion:** 2012-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01450072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01450072, "Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01450072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*